Eikon Therapeutics, Inc. (EIKN) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-08-03 | 8-K | Officer / Director Changes | SEC |
| 2026-06-10 | 8-K | Officer / Director Changes | SEC |
| 2026-06-01 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-11 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-06 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.